The Journal of Infectious Diseases · 2010 · 125 citations · 12 references
Life SciencesInfectious DiseasesMicrobiologyBiomaterialsMedical MicrobiologyMicrobial EcologyAntifungal TherapyAntimicrobial BiomaterialsBiofilm FormationBiofilm Formation In InfectionCatheter-associated Infection PreventionMicrobial BiofilmsAntifungal TreatmentsBiofilm DynamicsBiofilm GrowthCandida Biofilm PreventionCandida BiofilmsCatheter-associated BiofilmsChitosanChitosan Treatment
Candida species are a major cause of catheter infections. Using a central venous catheter Candida albicans biofilm model, we demonstrated that chitosan, a polymer isolated from crustacean exoskeletons, inhibits candidal biofilm formation in vivo. Furthermore, chitosan statistically significantly decreased both the metabolic activity of the biofilms and the cell viability of C. albicans and Candida parapsilosis biofilms in vitro. In addition, confocal and scanning electron microscopic examination demonstrated that chitosan penetrates candidal biofilms and damages fungal cells. Importantly, the concentrations of chitosan that were used to evaluate fungal biofilm susceptibility were not toxic to human endothelial cells. Chitosan should be considered for the prevention or treatment of fungal biofilms on central venous catheters and perhaps other medical devices.
12
Guidelines for Treatment of Candidiasis
Peter G. Pappas, John Rex, Jack D. Sobel et al. · Clinical Infectious Diseases · 2004 · 1.4K citations · Full text
Antibacterial action of chitosan
Nikita Sudarshan, Dallas G. Hoover, Dietrich Knorr · Food Biotechnology · 1992 · 988 citations
Intravascular Catheter Exchange and Duration of Candidemia
John Rex, John E. Bennett, Alan M. Sugar et al. · Clinical Infectious Diseases · 1995 · 254 citations